Table 2.
Duration (days) of symptoms from the day of randomization and the significance of the difference between groups A (ADAPT-232) and B (placebo).
| Group A ADAPT |
Group B Placebo |
Significance of Difference |
|||||
|---|---|---|---|---|---|---|---|
| Parameters | Mean | SD | n | Mean | SD | n | p Value |
| Fatigue, days | 11.96 | 4.899 | 49 | 12.98 | 0.648 | 50 | 0.2662 b |
| Headache, days | 10.40 | 5.336 | 45 | 9.244 | 4.700 | 41 | 0.3582 b |
| Respiration problems, days | 6.579 | 3.485 | 19 | 6.895 | 5.259 | 19 | 0.7619 b |
| Organoleptic disfunctions, days | 11.58 | 6.543 | 26 | 10.64 | 5.728 | 22 | 0.8383 b |
| Hair loss, days | 16.70 | 5.823 | 33 | 15.41 | 5.231 | 37 | 0.3317 a |
| Cough, days | 8.094 | 4.855 | 32 | 6.259 | 4.809 | 27 | 0.0219 b |
| Pain in muscles, chest and joints, days | 10.67 | 6.056 | 46 | 11.77 | 6.243 | 44 | 0.3668 b |
| Sweatiness, days | 12.07 | 6.211 | 44 | 12.24 | 6.102 | 41 | 0.7605 b |
| Average duration of all symptoms, days | 7.640 | 2.724 | 50 | 7.463 | 2.469 | 50 | 0.5375 b |
| Stay at home/sick-listed, days | 5.918 | 9.089 | 49 | 5.940 | 9.224 | 50 | 0.9839 b |
a—parametric unpaired t-test; b—non-parametric Mann–Whitney test.